R
Über
René R. Kuijten is a Partner and Head of EQT Life Sciences. He is listed as the responsible advisor for Neuravi, a company that developed an innovative stroke treatment and was acquired by Johnson & Johnson in 2017.
Schwerpunkte
BioTech, HealthTech, Medical Devices, Diagnostics
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...